步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603858 步长制药

已收盘 11-22 15:00:00

{"stockData":{"symbol":"603858","market":"SH","secType":"STK","nameCN":"步长制药","latestPrice":16.37,"timestamp":1732258800000,"preClose":17,"halted":0,"volume":7011145,"delay":0,"floatShares":1106000000,"shares":1106000000,"eps":-0.2652,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.63,"latestTime":"11-22 15:00:00","open":16.98,"high":17.02,"low":16.35,"amount":117000000,"amplitude":0.0394,"askPrice":16.38,"askSize":46,"bidPrice":16.37,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-0.2652,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":17,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":18.7,"lowLimit":15.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1106042645,"pbRate":1.62,"roa":"--","roe":"2.73%","epsLYR":0.2884,"committee":-0.525705,"marketValue":18106000000,"floatMarketCap":18106000000,"peRate":-61.727001,"changeRate":-0.0371,"turnoverRate":0.0063,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-11-25。"},"requestUrl":"/m/hq/s/603858","defaultTab":"news","newsList":[{"id":"2485240330","title":"步长制药拟1113万元投资设立六家控股子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2485240330","media":"新京报","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485240330?lang=zh_cn&edition=full","pubTime":"2024-11-23 09:53","pubTimestamp":1732326780,"startTime":"0","endTime":"0","summary":"11月22日，步长制药发布公告，拟出资共计1113万元对外投资设立六家控股子公司，分别为山东步长传方药业有限公司、步长联创商贸有限公司、步长鼎鑫商贸有限公司、步长脉利通商贸有限公司、步长众福寿药业有限公司、山东步长瑞丰科技有限公司，相关人员拟对本次投资进行跟投。步长制药表示，本次设立新公司有利于公司战略发展布局，为公司未来发展奠定良好基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123095705a24f3109&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123095705a24f3109&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603858","BK0196"],"gpt_icon":0},{"id":"2485231535","title":"步长制药(603858.SH)拟出资共计1113万元设立六家控股子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2485231535","media":"智通财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485231535?lang=zh_cn&edition=full","pubTime":"2024-11-22 17:20","pubTimestamp":1732267258,"startTime":"0","endTime":"0","summary":"智通财经APP讯，步长制药 发布公告，公司为完善战略发展布局，在细分管理的基础上获取市场竞争优势，促进业务发展，拟出资共计1113万元对外投资设立六家控股子公司，分别为山东步长传方药业有限公司、步长联创商贸有限公司、步长鼎鑫商贸有限公司、步长脉利通商贸有限公司、步长众福寿药业有限公司、山东步长瑞丰科技有限公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603858","BK0196","BK0239"],"gpt_icon":0},{"id":"2485231517","title":"步长制药：拟出资共计1113万元设立六家控股子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2485231517","media":"格隆汇","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485231517?lang=zh_cn&edition=full","pubTime":"2024-11-22 17:16","pubTimestamp":1732267013,"startTime":"0","endTime":"0","summary":"格隆汇11月22日丨步长制药公布，公司为完善战略发展布局，在细分管理的基础上获取市场竞争优势，促进业务发展，拟出资共计1,113万元对外投资设立六家控股子公司，分别为山东步长传方药业有限公司、步长联创商贸有限公司、步长鼎鑫商贸有限公司、步长脉利通商贸有限公司、步长众福寿药业有限公司、山东步长瑞丰科技有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122172117a24d8a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122172117a24d8a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603858","BK0196"],"gpt_icon":0},{"id":"2485095457","title":"步长制药全资子公司获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485095457","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485095457?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:33","pubTimestamp":1732181632,"startTime":"0","endTime":"0","summary":"财中社11月21日电步长制药 发布公告，称其全资子公司山东丹红制药有限公司近日获得国家药品监督管理局核准签发的磷酸西格列汀片及孟鲁司特钠咀嚼片的药品注册证书。此次获得药品注册证书将有助于公司优化产品结构，提升生产能力，以满足市场需求，预计对未来经营产生积极影响。2024年前三季度，步长制药实现收入85.14亿元，归母净利润3.13亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121175000a24aeabb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121175000a24aeabb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2485452567","title":"步长制药(603858.SH)子公司获磷酸西格列汀片及孟鲁司特钠咀嚼片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485452567","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485452567?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:20","pubTimestamp":1732180850,"startTime":"0","endTime":"0","summary":"智通财经APP讯，步长制药 发布公告，公司全资子公司山东丹红制药有限公司近日收到国家药品监督管理局核准签发的关于磷酸西格列汀片及孟鲁司特钠咀嚼片的《药品注册证书》。磷酸西格列汀片适应症：1、单药治疗。孟鲁司特钠咀嚼片适用于2岁至14岁儿童哮喘的预防和长期治疗，包括预防白天和夜间的哮喘症状，治疗对阿司匹林敏感的哮喘患者以及预防运动诱发的支气管收缩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603858","BK0196"],"gpt_icon":0},{"id":"2485452256","title":"步长制药最新公告：全资子公司获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485452256","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485452256?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:20","pubTimestamp":1732180843,"startTime":"0","endTime":"0","summary":"步长制药公告，全资子公司山东丹红制药有限公司近日收到国家药品监督管理局核准签发的关于磷酸西格列汀片及孟鲁司特钠咀嚼片的《药品注册证书》。磷酸西格列汀片适应症包括单药治疗、与二甲双胍联用、与磺脲类药物联用、与胰岛素联用，用于改善2型糖尿病患者的血糖控制。孟鲁司特钠咀嚼片适用于2岁至14岁儿童哮喘的预防和长期治疗，以及减轻过敏性鼻炎引起的症状。公司在两个药品项目上的研发费用约为1851.00万元和1192.35万元。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100028954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2485458295","title":"步长制药11月21日遭主力抛售280万元 环比增加207.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485458295","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485458295?lang=zh_cn&edition=full","pubTime":"2024-11-21 15:21","pubTimestamp":1732173700,"startTime":"0","endTime":"0","summary":"11月21日, 步长制药股价跌0.23%，报收17.00元，成交金额7680万元，换手率0.41%，振幅1.17%，量比0.76。步长制药今日主力资金净流出280万元，上一交易日主力净流出91万元，今日环比增加207.69%。该股近5个交易日下跌0.18%，主力资金累计净流出1243万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出6454万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153947a24aa09f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153947a24aa09f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2484198694","title":"步长制药：人知降糖胶囊获批首家中药二级保护品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2484198694","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484198694?lang=zh_cn&edition=full","pubTime":"2024-11-20 17:47","pubTimestamp":1732096027,"startTime":"0","endTime":"0","summary":"格隆汇11月20日丨步长制药公布，近日，国家药品监督管理局网站发布《中药保护品种公告》，批准山东步长制药股份有限公司全资子公司陕西步长制药有限公司药品人知降糖胶囊为首家中药二级保护品种。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120175151a2482b6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120175151a2482b6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2484967167","title":"步长制药最新公告：全资子公司药品人知降糖胶囊获批首家中药二级保护品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2484967167","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484967167?lang=zh_cn&edition=full","pubTime":"2024-11-20 17:39","pubTimestamp":1732095580,"startTime":"0","endTime":"0","summary":"步长制药公告，国家药品监督管理局批准公司全资子公司陕西步长制药有限公司药品人知降糖胶囊为首家中药二级保护品种。该药品功能主治为益气养阴，清热生津，用于Ⅱ型糖尿病属气阴两虚兼燥热伤津证的辅助治疗。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000031486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603858","BK0196","BK0239"],"gpt_icon":0},{"id":"2484162904","title":"步长制药(603858.SH)子公司药品人知降糖胶囊获批首家中药二级保护品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2484162904","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484162904?lang=zh_cn&edition=full","pubTime":"2024-11-20 17:33","pubTimestamp":1732095219,"startTime":"0","endTime":"0","summary":"智通财经APP讯，步长制药(603858.SH)发布公告，近日，国家药品监督管理局网站发布《中药保护品种公告(第20号)(2024年第140号)》，批准公司全资子公司陕西步长制药有限公司(简称“陕西步长”)药品人知降糖胶囊为首家中药二级保护品种。人知降糖胶囊为陕西步长独家品种，本次获批中药保护品种，是对该产品的临床价值、产品疗效和质量等方面的充分肯定，加强了该品种的知识产权保护，能够进一步提升人知降糖胶囊的市场竞争力和品牌影响力，进一步提高市场份额，对该产品的生产、销售、推广等具有积极意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2484614402","title":"步长制药11月18日主力资金流出572万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484614402","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484614402?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:20","pubTimestamp":1731914458,"startTime":"0","endTime":"0","summary":"11月18日, 步长制药股价跌0.59%，报收16.77元，成交金额1.18亿元，换手率0.63%，振幅2.13%，量比0.89。步长制药今日主力资金净流出572万元，连续7日净流出，上一交易日主力净流出764万元，今日环比减少25.13%。该股近5个交易日下跌4.39%，主力资金累计净流出4849万元；近20日主力资金累计净流出9354万元，其中净流出天数为15日。该行业中净流入前三个股分别为信邦制药、万邦德、葵花药业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154339abcbb473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154339abcbb473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2483060760","title":"步长制药全资子公司获药品生产许可证变更 新增“咳喘安口服液”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483060760","media":"财中社","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483060760?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:53","pubTimestamp":1731498801,"startTime":"0","endTime":"0","summary":"公告中提到，公司全资子公司杨凌步长获得陕西省药品监督管理局的许可，进行药品生产许可证的变更，主要包括分类码的调整及受托生产情况的更新，其他内容保持不变。此次变更增加了受托生产品种“咳喘安口服液”，委托方为陕西步长制药有限公司。公告指出，本次许可证变更有助于公司优化生产结构，保持稳定的生产能力，积极影响公司的未来经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113195930a233eca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113195930a233eca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","603858","BK0239"],"gpt_icon":0},{"id":"2483081840","title":"步长制药放弃控股子公司股权优先受让权","url":"https://stock-news.laohu8.com/highlight/detail?id=2483081840","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483081840?lang=zh_cn&edition=full","pubTime":"2024-11-13 18:38","pubTimestamp":1731494339,"startTime":"0","endTime":"0","summary":"公司控股子公司济南步长晟源的多位股东计划将各自持有的1.00%股权以1元/注册资本的价格转让给其他个人，转让后公司仍持有济南步长晟源90%的股权比例。公司决定放弃上述股权转让的优先受让权，此次交易未构成关联交易，也不需提交股东会审议批准。公司表示，放弃优先受让权的决定符合整体发展战略，不会对公司的财务状况和经营成果产生重大不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113191926a233cc5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113191926a233cc5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603858","BK0239","BK0196"],"gpt_icon":0},{"id":"2483072660","title":"步长制药：拟放弃优先受让投资基金份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2483072660","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483072660?lang=zh_cn&edition=full","pubTime":"2024-11-13 18:37","pubTimestamp":1731494223,"startTime":"0","endTime":"0","summary":"格隆汇11月13日丨步长制药(603858.SH)公布，公司作为有限合伙人参与认购投资的投资基金瑞伏医疗有限合伙人上犹益憬拟将其持有的1,551万元基金份额转让给自然人安惊川，公司同意放弃优先受让权。交易完成后，公司持有瑞伏医疗15.5457%基金份额不变。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113184136abbd360b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113184136abbd360b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603858","BK0196","BK0239"],"gpt_icon":0},{"id":"2483670074","title":"步长制药最新公告：全资子公司药品临床试验取得受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2483670074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483670074?lang=zh_cn&edition=full","pubTime":"2024-11-13 18:31","pubTimestamp":1731493861,"startTime":"0","endTime":"0","summary":"步长制药公告，公司全资子公司保定天浩制药有限公司的“复方硫酸钠片”药品注册临床试验申请获国家药品监督管理局受理。该药品适用于成人肠镜检查前的结肠清洁，属于化学药品3类。公司在该项目上投入的研发费用约为214.39万元。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300030518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","03347","BK1576","BK0196","BK1141","BK1583","603858"],"gpt_icon":0},{"id":"2483408071","title":"步长制药：复方硫酸钠片临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2483408071","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483408071?lang=zh_cn&edition=full","pubTime":"2024-11-13 18:26","pubTimestamp":1731493606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","BK1574","603858","BK1583","01477","BK0196","BK1191","03347","BK1576","BK0239"],"gpt_icon":0},{"id":"2482411203","title":"步长制药业绩再度下滑 核心品种被重点监控的“危机”未了","url":"https://stock-news.laohu8.com/highlight/detail?id=2482411203","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482411203?lang=zh_cn&edition=full","pubTime":"2024-11-09 15:44","pubTimestamp":1731138240,"startTime":"0","endTime":"0","summary":"从步长制药对业绩下滑原因的解释来看，主要是部分产品因医保受限或被部分省份纳入重点监控目录使得销售规模下降、主要产品中药材价格比上年同期上涨以及本期政府补助比上年同期减少等综合影响。国家已全面推广医保受限及辅助用药重点监控政策。对于今年前三季度销售费用的大幅下滑，步长制药未给出原因。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109154527abb01e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109154527abb01e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2481971313","title":"步长制药：公司将严格按照《上海证券交易所股票上市规则》等相关规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2481971313","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481971313?lang=zh_cn&edition=full","pubTime":"2024-11-07 19:00","pubTimestamp":1730977240,"startTime":"0","endTime":"0","summary":"证券之星消息，步长制药11月07日在投资者关系平台上答复投资者关心的问题。公司将严格按照《上海证券交易所股票上市规则》等相关规定及时履行信息披露义务，谢谢。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107190232a2206214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107190232a2206214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","603858","BK0239"],"gpt_icon":0},{"id":"2481780859","title":"步长制药回购4485万股 占总股本的4.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481780859","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481780859?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:44","pubTimestamp":1730972640,"startTime":"0","endTime":"0","summary":"财中社11月7日电步长制药 发布关于股份回购实施结果暨股份变动的公告。经过实施，公司实际回购4485万股，占总股本的4.06%，实际回购金额达到7.12亿元，回购价格区间为14.16元/股至17.44元/股。公司表示，回购不会对经营、财务及未来发展产生重大影响，股权分布仍符合上市条件，不会影响公司的控制权。若在未来三年内未能实施完毕，未转让股份将依法减少注册资本。2024年前三季度，步长制药实现收入85.14亿元，归母净利润3.13亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107174720a2202bd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107174720a2202bd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0239","603858"],"gpt_icon":0},{"id":"2481927311","title":"步长制药(603858.SH)耗资7.12亿元完成回购4.06%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2481927311","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481927311?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:19","pubTimestamp":1730971180,"startTime":"0","endTime":"0","summary":"智通财经APP讯，步长制药(603858.SH)发布公告，2024年11月6日，公司完成了本次回购。公司通过集中竞价交易方式已累计回购公司股份4485.36万股，已回购股份占公司总股本的比例为4.06%，购买的最高价为17.44元/股，最低价为14.16元/股，累计已支付的总金额为7.12亿元(含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK0239","603858"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-11-18","address":"山东省菏泽市牡丹区中华西路369号","stockEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0404},{"period":"3month","weight":0.1144},{"period":"6month","weight":0.0283},{"period":"1year","weight":-0.0805},{"period":"ytd","weight":-0.0298}],"companyName":"山东步长制药股份有限公司","boardCode":"AI0027","perCapita":"17189股","boardName":"医药制造业","registeredCapital":"110604万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":"　　山东步长制药股份有限公司主要从事中成药的研发、生产和销售。主要产品涉及心脑血管疾病中成药领域，同时也覆盖妇科用药等其他领域，目前，公司正向生物制药、疫苗等医药高科技领域进军与扩张。","serverTime":1732344575765,"listedPrice":55.88,"stockholders":"64344人(较上一季度减少5.04%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"步长制药,603858,步长制药股票,步长制药股票老虎,步长制药股票老虎国际,步长制药行情,步长制药股票行情,步长制药股价,步长制药股市,步长制药股票价格,步长制药股票交易,步长制药股票购买,步长制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"步长制药(603858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供步长制药(603858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}